Pharmacokinetics of Afamelanotide in Erythropoietic Protoporphyria Patients
NCT06388642
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
28
Enrollment
INDUSTRY
Sponsor class
Conditions
Erythropoietic Protoporphyria
Interventions
DRUG:
Afamelanotide 16mg implant
Sponsor
Clinuvel Europe Limited